ResMed Inc.
RMD
•Stock Analysis$268.09
+0.00 (+0.00%)• Live
ResMed Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for ResMed Inc.
Key Financial Metrics
for ResMed Inc.
P/E Ratio
28.08
Revenue Growth
+10.95%
EPS Growth
+13.40%
Market Cap
$36.86B
Dividend Yield
+0.84%
Debt/Equity
0.15
ROIC
+20.14%
FCF Yield
+4.24%
View additional metrics
Valuation
P/B Ratio6.65
EV/Sales7.32
Financial Health
Current Ratio3.41
Return on Assets+30.63%
Analyst Recommendations
for ResMed Inc.
34 analysts
Consensus: Hold
About
for ResMed Inc.
Company Details
for ResMed Inc.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael J. Farrell BE, MBA, SM
Employees
9,980
Market Cap
39.25B
Exchange
New York Stock Exchange
IPO Date
June 2, 1995
Website
www.resmed.comCIK
0000943819
ISIN
US7611521078
CUSIP
761152107
Country
US
Balance Sheet
for ResMed Inc.
Cash Flow Statement
for ResMed Inc.
Income Statement
for ResMed Inc.
News
No news available at the moment.